Avacta Group Plc (LON:AVCT - Get Free Report) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 40.26 ($0.55) and traded as low as GBX 31.31 ($0.42). Avacta Group shares last traded at GBX 32.44 ($0.44), with a volume of 2,904,912 shares changing hands.
Avacta Group Price Performance
The company has a market cap of £117.32 million, a P/E ratio of -3.97 and a beta of 1.12. The company has a fifty day moving average price of GBX 33.45 and a two-hundred day moving average price of GBX 40.26. The company has a debt-to-equity ratio of 52.53, a quick ratio of 4.96 and a current ratio of 1.29.
Avacta Group (LON:AVCT - Get Free Report) last announced its quarterly earnings data on Friday, June 6th. The biotechnology company reported GBX (8.54) (($0.12)) earnings per share for the quarter. Avacta Group had a negative net margin of 114.45% and a negative return on equity of 74.00%. On average, sell-side analysts anticipate that Avacta Group Plc will post -9.9011833 earnings per share for the current fiscal year.
Avacta Group Company Profile
(
Get Free Report)
Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.
Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Avacta Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avacta Group wasn't on the list.
While Avacta Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
